TLDR A 9-year-old girl developed type 1 diabetes and alopecia after being treated for a rare kidney disease.
A 9-year-old female initially diagnosed with membranous glomerulonephritis and treated with methylprednisolone, prednisolone, cyclophosphamide, and Mycophenolate mofetil, later developed type 1 diabetes mellitus (T1DM) and alopecia areata. This case highlights the association of T1DM with other autoimmune diseases, including membranoproliferative glomerulonephritis, which is rare in pediatric patients. Her thyroid function, celiac screen, liver enzymes, and other relevant tests were normal. This is the first reported pediatric case of such an association.
12 citations
,
February 2023 in “Journal of Personalized Medicine” Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.
32 citations
,
March 2015 in “The Journal of Clinical Endocrinology & Metabolism” Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.
2 citations
,
August 2022 in “Federal Practitioner” A severe medication reaction required long treatment and led to hair loss and thyroid issues.
9 citations
,
May 2023 in “Inflammation Research” New small molecule drugs show promise in treating complex skin diseases but need more safety research.
1 citations
,
January 2017 in “The Annals of Clinical and Analytical Medicine” Vitamin D receptor gene changes don't affect alopecia areata risk.
86 citations
,
October 2017 in “Translational pediatrics” Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.